You just read:

Conference Schedules, Stock Price Movements, Executive Transitions, and Revenue Outlook - Research Report on Incyte, ViroPharma, Cooper, Varian and PDL BioPharma

News provided by

Analysts' Corner

Dec 30, 2013, 08:00 ET